Hepatocellular Hypertrophy and Cell Proliferation in Sprague-Dawley Rats Following Dietary Exposure to Ammonium Perfluorooctanoate Occurs through Increased Activation of the Xenosensor Nuclear Receptors PPARα and CAR/PXR
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Ammonium perfluorooctanoate (APFO), a processing aid used in the production of fluoropolymers, produces hepatomegaly and hepatocellular hypertrophy in rodents. In mice, APFO-induced hepatomegaly is associated with increased activation of the xenosensor nuclear receptors, PPARα and CAR/PXR. Although non-genotoxic, chronic dietary treatment of Sprague-Dawley (S-D) rats with APFO produced an increase in benign tumours of the liver, acinar pancreas, and testicular Leydig cells. Most of the criteria for establishing a PPARα-mediated mode of action for the observed hepatocellular tumours have been previously established with the exception of the demonstration of increased hepatocellular proliferation. The present study evaluates the potential roles for APFO-induced activation of PPARα and CAR/PXR with respect to liver tumour production in the S-D rat and when compared to the specific PPARα agonist, 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid (Wy 14,643). Male S-D rats were fed APFO (300 ppm in diet) or Wy 14,643 (50 ppm in diet) for either 1, 7, or 28 days. Effects of treatment with APFO included: decreased body weight; hepatomegaly, hepatocellular hypertrophy, hepatocellular hyperplasia (microscopically and by BrdU labelling index), and hepatocellular glycogen loss; increased activation of PPARα (peroxisomal β-oxidation and microsomal CYP4A1 protein); decreased plasma triglycerides, cholesterol, and glucose; increased activation of CAR (CYP2B1/2 protein) and CAR/PXR (CYP3A1 protein). Responses to treatment with Wy 14,643 were consistent with increased activation of PPARα, specifically: increased CYP4A1 and peroxisomal β-oxidation; increased hepatocellular hypertrophy and cell proliferation; decreased apoptosis; and hypolipidaemia. With the exception of decreased apoptosis, the effects observed with Wy 14,643 were noted with APFO, and APFO was less potent. These data clearly demonstrate an early hepatocellular proliferative response to APFO treatment and suggest that the hepatomegaly and tumours observed after chronic dietary exposure of S-D rats to APFO likely are due to a proliferative response to combined activation of PPARα and CAR/PXR. This mode of action is unlikely to pose a human hepatocarcinogenic hazard.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In rodents, these compounds appear to exert toxicological effects by binding to and activating the peroxisome proliferator receptor alpha (PPARα), a transcription factor that regulates lipid metabolism, energy balance and inflammation [28,29,30,31].”
From The EU’s Per- and Polyfluoroalkyl Substances (PFAS) Ban: A Case of Policy over Science (2023) · cites this paper as [28]
In the citing paper
“However, PPARα activators are unlikely to cause liver tumors in humans due to differences in biological response to PPARα activation in key downstream events [28,32,33].”
From The EU’s Per- and Polyfluoroalkyl Substances (PFAS) Ban: A Case of Policy over Science (2023) · cites this paper as [28]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331 · cited 1×
“The protein concentration of tissue heavy pellets was determined in aqueous solutions using a modiWcation of the method of Lowry et al. (1951) and bovine serum albumin”
MethodBurton, K. (1956) · Biochemical Journal · doi:10.1042/bj0620315 · Cited by 14,090
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,728
Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., & Seed, J. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm128 · Cited by 2,620 · cited 1×
“The toxicology of PFOA has been reviewed (Kennedy et al. 2004; Lau et al. 2007 ).”
BackgroundLee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
The toxicology of perfluorooctanoate
Kennedy, G. L., Butenhoff, J. L., Olsen, G. W., O'Connor, J. C., Seacat, A. M., Perkins, R. G., Biegel, L. B., Murphy, S. R., & Farrar, D. G. (2004) · Critical Reviews in Toxicology · doi:10.1080/10408440490464705 · Cited by 742
Self-citationThe nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism
Wei, P., Zhang, J., Egan-Hafley, M., Liang, S., & Moore, D. D. (2000) · Nature · doi:10.1038/35038112 · Cited by 654 · cited 1×
“Several studies using receptor KO mice have shown the requirement for active CAR, PXR, or PPAR for the expression of the complete hypertrophic and hyperplastic changes characteristic of liver growth–inducing agents (Lee et al. 1995; Wei et al. 2000; Huang et al. 2005; Scheer et al. 2008).”
BackgroundPPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance
Klaunig, J. E., Babich, M. A., Baetcke, K. P., Cook, J. C., Corton, J. C., David, R. M., DeLuca, J. G., Lai, D. Y., McKee, R. H., Peters, J. M., et al. (2003) · Critical Reviews in Toxicology · doi:10.1080/713608372 · Cited by 611
Vanden Heuvel, J. P., Thompson, J. T., Frame, S. R., & Gillies, P. J. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl014 · Cited by 479 · cited 2×
“As stated in the introduction, PFOA has been conWrmed to activate and to be a ligand for the xenosensor nuclear receptor PPAR (Bjork and Wallace 2009; Maloney and Waxman 1999; Nakamura et al. 2009; Rosen et al. 2008a; Takacs and Abbott 2007; Vanden Heuvel et al. 2006; Wolf et al. 2008).”
BackgroundTakacs, M. L., & Abbott, B. D. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfl135 · Cited by 396
Research works printed but not linked: 1
- Sibinski LJ, Allen JL, Erickson EE (1983) Two year oral (diet) toxicity/carcinogenicity study of fluorochemical FC-143 in rats. Expt. No. 0281CR0012. Available on USEPA Docket AR226–0437-0440. Riker Laboratories, Inc., St. Paul
Cited by
Post, G. B., Cohn, P. D., & Cooper, K. R. (2012) · Environmental Research · doi:10.1016/j.envres.2012.03.007 · Cited by 639
Per- and polyfluorinated substances (PFASs): Environmental challenges
Krafft, M. P., & Riess, J. G. (2015) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2015.07.004 · Cited by 294
Molecular mechanisms of PFOA-induced toxicity in animals and humans: Implications for health risks
Li, K., Gao, P., Xiang, P., Zhang, X., Cui, X., & Ma, L. Q. (2017) · Environment International · doi:10.1016/j.envint.2016.11.014 · Cited by 260
“Elcombe et al. (2010) then demonstrated that CAR and PXR expression was increased in male rats after exposing to APFO in diet for 28 d.”
Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes
Bjork, J. A., Butenhoff, J. L., & Wallace, K. B. (2011) · Toxicology · doi:10.1016/j.tox.2011.06.012 · Cited by 259
Self-citationOverview of emerging contaminants and associated human health effects
Lei, M., Zhang, L., Lei, J., Zong, L., Li, J., Wu, Z., & Wang, Z. (2015) · BioMed Research International · doi:10.1155/2015/404796 · Cited by 231
PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling
Rosen, M. B., Das, K. P., Rooney, J., Abbott, B., Lau, C., & Corton, J. C. (2017) · Toxicology · doi:10.1016/j.tox.2017.05.013 · Cited by 214
“Activation of CAR by PFOA and PFOS has previously been demonstrated in either rodents or by in vitro studies (Cheng and Klaassen, 2008; Ren et al., 2009; Elcombe et al., 2010; Bjork et al., 2011; Elcombe et al., 2012).”
BackgroundChang, E. T., Adami, H.-O., Boffetta, P., Cole, P., Starr, T. B., & Mandel, J. S. (2014) · Critical Reviews in Toxicology · doi:10.3109/10408444.2014.905767 · Cited by 180
“…α ) and, possibly as well, the constitutive androstane receptor (CAR) and the pregnane X receptor (PXR), in the production of benign liver tumors by both of these chemicals (Corton et al. 2014, Elcombe et al. 2010, Elcombe et al. 2012, Elcombe et al. 2014, Klaunig et al. 2003, Klaunig et al. 2012).”
BackgroundChang, E. T., Adami, H.-O., Boffetta, P., Wedner, H. J., & Mandel, J. S. (2016) · Critical Reviews in Toxicology · doi:10.3109/10408444.2015.1122573 · Cited by 173
“…receptor alpha (PPARa), and possibly also the constitutive androstane receptor (CAR) and the pregnane X receptor (PXR), is a key event in some PFOA- and PFOS-mediated toxicities in laboratory animals (Corton et al. 2014; Elcombe et al. 2010, 2012, 2014; Klaunig et al. 2003; Klaunig et al. 2012).”
BackgroundWolf, C. J., Schmid, J. E., Lau, C., & Abbott, B. D. (2012) · Reproductive Toxicology · doi:10.1016/j.reprotox.2011.09.009 · Cited by 160
Borg, D., Lund, B.-O., Lindquist, N.-G., & Håkansson, H. (2013) · Environment International · doi:10.1016/j.envint.2013.05.009 · Cited by 155
Houck, K. A., Patlewicz, G., Richard, A. M., Williams, A. J., Shobair, M. A., Smeltz, M., Clifton, M. S., Wetmore, B., Medvedev, A., & Makarov, S. (2021) · Toxicology · doi:10.1016/j.tox.2021.152789 · Cited by 147
Negri, E., Metruccio, F., Guercio, V., Tosti, L., Benfenati, E., Bonzi, R., La Vecchia, C., & Moretto, A. (2017) · Critical Reviews in Toxicology · doi:10.1080/10408444.2016.1271972 · Cited by 142
“Perfluorinated alkyl acids, including PFOA and PFOS, are structurally similar di-free fatty acids and thus have the ability to interact with membranes and nuclear receptor, peroxisome proliferator-activated receptor (PPARa), as well as other nuclear receptors such as constitutive androstane receptor (CAR) and pregnane…”
BackgroundLoccisano, A. E., Campbell, J. L., Andersen, M. E., & M.A., H. J. C. I. (2010) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2010.12.004 · Cited by 154
“These compounds also activate nuclear receptors PPAR-a and CAR/PXR known to be associated with a hypertrophic response in liver tissue (Elcombe et al., 2010; Rosen et al., 2010).”
BackgroundPeritore, A. F., Gugliandolo, E., Cuzzocrea, S., Crupi, R., & Britti, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411707 · Cited by 158
“It was demonstrated that CAR and PXR expression was increased in male rats after exposing to Ammonium perfluorooctanoate (APFO) in diet for 28 d [25].”
BackgroundFisher, M. M., Arbuckle, T. E., Wade, M., & Haines, D. A. (2012) · Environmental Research · doi:10.1016/j.envres.2012.11.006 · Cited by 141
Modeled Perfluorooctanoic Acid (PFOA) Exposure and Liver Function in a Mid-Ohio Valley Community
Darrow, L. A., Groth, A. C., Winquist, A., Shin, H.-M., Bartell, S. M., & Steenland, K. (2016) · Environmental Health Perspectives · doi:10.1289/ehp.1510391 · Cited by 126
“These effects are at least partially mediated by activation of the peroxisome proliferator-activated receptor-alpha (PPAR-α ), a major regulator of lipid metabolism in the liver, but also involve the activation of other nuclear receptors (Bjork et al. 2011; Elcombe et al. 2010).”
Goodrum, P. E., Anderson, J. K., Luz, A. L., & Ansell, G. K. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfaa123 · Cited by 118
Lau, C. S. (2012) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-7643-8340-4_3 · Cited by 113
Biotransformation of fluorotelomer compound to perfluorocarboxylates in humans
Nilsson, H., Kärrman, A., Rotander, A., van Bavel, B., Lindström, G., & Westberg, H. (2013) · Environment International · doi:10.1016/j.envint.2012.09.001 · Cited by 102
“PFOA is associated with liver toxicity, immunotoxicity, fatty acid metabolism, and developmental toxicity in rodents and humans (Elcombe et al., 2010; Fei et al., 2007; Klaunig et al., 2011; Lau et al., 2006; Yang et al., 2000).”
BackgroundMode of Action analysis of perfluorooctanoic acid (PFOA) tumorigenicity and Human Relevance
Klaunig, J. E., Hocevar, B. A., & Kamendulis, L. M. (2011) · Reproductive Toxicology · doi:10.1016/j.reprotox.2011.10.014 · Cited by 101
Mortality and cancer incidence in ammonium perfluorooctanoate production workers
Raleigh, K. K., Alexander, B. H., Olsen, G. W., Ramachandran, G., Morey, S. Z., Church, T. R., Logan, P. W., Scott, L. L. F., & Allen, E. M. (2014) · Occupational and Environmental Medicine · doi:10.1136/oemed-2014-102109 · Cited by 96
Differential toxicity between perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA)
Tsuda, S. (2016) · The Journal of Toxicological Sciences · doi:10.2131/jts.41.sp27 · Cited by 96
“However, Elcombe et al. (2010) failed to find PFOA-induced apoptosis that hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats following dietary exposure to PFOA occurred without affecting apoptosis through increased activation of PPARα and CAR/PXR, while a PPAR α agonist (Wy…”
BackgroundAbbott, B. D., Wood, C. R., Watkins, A. M., Tatum-Gibbs, K. R., Das, K. P., & Lau, C. S. (2011) · Reproductive Toxicology · doi:10.1016/j.reprotox.2011.11.005 · Cited by 98
Sonthithai, P., Suriyo, T., Thiantanawat, A., Watcharasit, P., Ruchirawat, M., & Satayavivad, J. (2016) · Journal of Applied Toxicology · doi:10.1002/jat.3210 · Cited by 92
“…on body weight, hepatomegaly, neurotoxicity, thyroid hormone alteration, immune modulation, delayed mammary gland development, and impairment of the reproductive and developmental systems (Butenhoff et al., 2002; White et al., 2007; Wolf et al., 2007; Chang et al., 2008; Elcombe et al., 2010) .”
BackgroundPregnane xenobiotic receptor in cancer pathogenesis and therapeutic response
Pondugula, S. R., & Mani, S. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.08.030 · Cited by 90
Loccisano, A. E., Campbell, J. L., Butenhoff, J. L., Andersen, M. E., & M.A., H. J. C. I. (2011) · Reproductive Toxicology · doi:10.1016/j.reprotox.2011.04.006 · Cited by 92
Self-citationThe EU’s Per- and Polyfluoroalkyl Substances (PFAS) Ban: A Case of Policy over Science
Spyrakis, F., & Dragani, T. A. (2023) · Toxics · doi:10.3390/toxics11090721 · Cited by 78
“However, PPARα activators are unlikely to cause liver tumors in humans due to differences in biological response to PPARα activation in key downstream events [28,32,33].”
BackgroundButenhoff, J. L., Bjork, J. A., Chang, S.-C., Ehresman, D. J., Parker, G. A., Das, K., Lau, C., Lieder, P. H., van Otterdijk, F. M., & Wallace, K. B. (2012) · Reproductive Toxicology · doi:10.1016/j.reprotox.2011.08.004 · Cited by 75
Self-citationChiu, W. A., Guyton, K. Z., Martin, M. T., Reif, D. M., & Rusyn, I. (2017) · ALTEX · doi:10.14573/altex.1703231 · Cited by 79
“This outcome is consistent with observations that multiple nuclear receptors are activated by PFOA in vivo in rodents (Elcombe et al., 2010; Rosen et al., 2010).”
ResultButenhoff, J. L., Kennedy, G. L., Chang, S., & Olsen, G. W. (2012) · Toxicology · doi:10.1016/j.tox.2012.04.001 · Cited by 80
Self-citationMaxwell, D. L., Oluwayiose, O. A., Houle, E., Roth, K., Nowak, K., Sawant, S., Paskavitz, A. L., Liu, W., Gurdziel, K., Petriello, M. C., et al. (2024) · Environment International · doi:10.1016/j.envint.2024.108577 · Cited by 79
Wolf, C. J., Rider, C. V., Lau, C., & Abbott, B. D. (2014) · Toxicology · doi:10.1016/j.tox.2013.12.002 · Cited by 69
“PFAAs activate PPAR in hepatocytes of rat, uman and chick (Bjork and Wallace, 2009; Cwinn et al., 2008; lcombe et al., 2010) and in transfected cell models (Maloney and axman, 1999; Shipley et al., 2004; Takacs and Abbott, 2007; anden Heuvel et al., 2006).”
Pregnane X Receptor and Cancer: Context-Specificity is Key
Pondugula, S. R., Pávek, P., & Mani, S. (2016) · Nuclear Receptor Research · doi:10.11131/2016/101198 · Cited by 74
“There are tissue/context specific consequences for PXR expression in cancer and normal tissues [30, 133].”
Schlezinger, J. J., Hyötyläinen, T., Sinioja, T., Boston, C. M., Puckett, H. M., Oliver, J., Heiger‐Bernays, W., & Webster, T. F. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115644 · Cited by 69
Fu, Y., Wang, T., Fu, Q., Wang, P., & Lü, Y. (2014) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2014.04.039 · Cited by 65
Ding, N., Harlow, S. D., Randolph, J. F., Calafat, A. M., Mukherjee, B., Batterman, S., Gold, E. B., & Park, S. K. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa303 · Cited by 57
Reproductive and developmental toxicity of potassium perfluorohexanesulfonate in CD-1 mice
Chang, S., Butenhoff, J. L., Parker, G. A., Coder, P. S., Zitzow, J. D., Krisko, R. M., Bjork, J. A., Wallace, K. B., & Seed, J. G. (2018) · Reproductive Toxicology · doi:10.1016/j.reprotox.2018.04.007 · Cited by 57
Self-citationThe effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice
Li, X., Wang, Z., & Klaunig, J. E. (2019) · Toxicology · doi:10.1016/j.tox.2019.01.017 · Cited by 62
Metabolism-Disrupting Chemicals and the Constitutive Androstane Receptor CAR
Küblbeck, J., Niskanen, J., & Honkakoski, P. (2020) · Cells · doi:10.3390/cells9102306 · Cited by 57
Tang, J., Jia, X., Gao, N., Wu, Y., Liu, Z., Lu, X., Du, Q., He, J., Li, N., Chen, B., et al. (2018) · Environmental Pollution · doi:10.1016/j.envpol.2018.02.037 · Cited by 57
Convertino, M., Church, T. R., Olsen, G. W., Liu, Y., Doyle, E., Elcombe, C. R., Barnett, A. L., Samuel, L. M., MacPherson, I. R., & Evans, T. R. J. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy035 · Cited by 54
“…rats and mice treated with APFO, liver effects such as increased serum ALT and AST values (Butenhoff et al., 2012a; Minata et al., 2010; Son et al., 2008); peroxisome proliferation with subsequent hepatocellular hypertrophy (Elcombe et al., 2010; Haughom and Spydevold, 1992; Loveless et al., 2006;)”
BackgroundResultSelf-citationSøderstrøm, S., Lille‐Langøy, R., Yadetie, F., Rauch, M., Milinski, A., Dejaegere, A. P., Stote, R. H., Goksøyr, A., & Karlsen, O. A. (2022) · Environment International · doi:10.1016/j.envint.2022.107203 · Cited by 58
Dixon, D., Reed, C. E., Moore, A. B., Gibbs-Flournoy, E. A., Hines, E. P., Wallace, E. A., Stanko, J. P., Lu, Y., Jefferson, W. N., Newbold, R. R., et al. (2012) · Reproductive Toxicology · doi:10.1016/j.reprotox.2011.10.011 · Cited by 51
“The mechanism of PFOA-induced effects, primarily in the liver, has traditionally been thought to occur strictly through a peroxisome proliferator–activated receptor α (PPARα) mechanism [16]; however, recent animal and epidemiologic data suggest that PFOA may cause endocrine disruption [14, 15, 17–19].”
Olsen, G. W., Ehresman, D. J., Buehrer, B. D., Gibson, B. A., Butenhoff, J. L., & Zobel, L. R. (2012) · Journal of Occupational & Environmental Medicine · doi:10.1097/jom.0b013e31825461d2 · Cited by 51
Self-citationWhy Toxic Equivalency Factors Are Not Suitable for Perfluoroalkyl Chemicals
Peters, J. M., & Gonzalez, F. J. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200316x · Cited by 48
Role of xenobiotics in the induction and progression of fatty liver disease
Klaunig, J. E., Li, X., & Wang, Z. (2018) · Toxicology Research · doi:10.1039/c7tx00326a · Cited by 55
Albrecht, P. P., Torsell, N. E., Krishnan, P., Ehresman, D. J., Frame, S. R., Chang, S.-C., Butenhoff, J. L., Kennedy, G. L., Gonzalez, F. J., & Peters, J. M. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kfs318 · Cited by 44
“…including postnatal lethality and hepatic effects (Abbott et al., 2007; Nakamura et al., 2009), there is also evidence from other studies suggesting that CAR and/or PXR may be required (Bjork et al., 2011; Cheng and Klaassen, 2008; Elcombe et al., 2010; Ren et al., 2009; Rosen et al., 2008).”
BackgroundSelf-citationButenhoff, J. L., Pieterman, E. J., Ehresman, D. J., Gorman, G. S., Olsen, G. W., Chang, S., & Princen, H. M. G. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.02.013 · Cited by 39
Self-citationHuman Health Risk Assessment of Perfluoroalkyl Acids
Butenhoff, J. L., & Rodricks, J. V. (2015) · Molecular and integrative toxicology · doi:10.1007/978-3-319-15518-0_15 · Cited by 32
Self-citationDose Effects of Ammonium Perfluorooctanoate on Lipoprotein Metabolism in APOE*3-Leiden.CETP Mice
Pouwer, M. G., Pieterman, E. J., Chang, S.-C., Olsen, G. W., Caspers, M. P. M., Verschuren, L., Jukema, J. W., & Princen, H. M. G. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz015 · Cited by 29
“Upstream regulator analysis also predicted the involvement of the xenosensor receptor PXR (Nr1l2) in the regulation of biological processes, whereas CAR (Nr1l3) mediated processes were affected to a much lesser extent, in line with literature (Elcombe et al., 2010).”
BackgroundResultSelf-citationPriority Environmental Contaminants
Tilley, S. K., & Fry, R. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801564-3.00006-7 · Cited by 33
Li, D., Jiang, L.-L., Hong, Y., & Cai, Z. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.115774 · Cited by 29
Wang, Z., Yao, J., Guo, H., Sheng, N., Guo, Y., & Dai, J. (2022) · Environmental Science & Technology · doi:10.1021/acs.est.2c00957 · Cited by 29
Evaluation of perfluorooctanoate for potential genotoxicity
Butenhoff, J. L., Kennedy, G. L., Jung, R., & Chang, S. (2014) · Toxicology Reports · doi:10.1016/j.toxrep.2014.05.012 · Cited by 26
Self-citationTang, Y., Vanlandingham, M. M., Wu, Y., Beland, F. A., Olson, G. R., & Fang, J. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2308-7 · Cited by 24
Roslan, M. Q. J., & Aris, A. Z. (2023) · Journal of environmental chemical engineering · doi:10.1016/j.jece.2023.111345 · Cited by 23
Xie, G., Song, Y., Li, N., Zhang, Z., Wang, X., Liu, Y., Jiao, S., Wei, M., Yu, B., Wang, Y., et al. (2021) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-20-688 · Cited by 22
“Short-term PPARα agonist treatment was shown to induce hepatocyte proliferation and hepatomegaly in rodents (15,37,38), which is mainly hepatocyte PPARα dependent, as either wholebody or hepatocyte-specific PPARα knockout completely abolished this hepatic proliferation (18,20).”
BackgroundMetabolomics: biomarkers of disease and drug toxicity
Stewart, J. D., & Bolt, H. M. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0635-4 · Cited by 21
“Biomarker research in combination with in vitro systems and mathematical modelling is one of the cutting-edge topics in toxicology (Read et al. 2010; Payan et al. 2009; Devi et al. 2007; Hewitt et al. 2007 ;H o¨hme et al. 2007, 2010; Carmo et al. 2006, 2007; Kafert-Kasting et al. 2006; Elcombe et al. 2010 ).”
Bull, S., Burnett, K., Vassaux, K., Ashdown, L., Brown, T., & Rushton, L. (2014) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2014.en-572 · Cited by 26
Mixture effects of two plant protection products in liver cell lines
Zahn, E., Wolfrum, J., Knebel, C., Heise, T., Weiß, F., Poetz, O., Marx‐Stoelting, P., & Rieke, S. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.12.067 · Cited by 19
“This adverse outcome is related to the activation of nuclear receptors, like PXR (Pregnane-X-Receptor), CAR (Constitutive Androstane Receptor) and AhR (Aryl hydrocarbon Receptor) and increased synthesis of xenobiotic metabolizing enzymes (Elcombe et al. 2010; Wei et al. 2000; Zhang et al. 2015).”
BackgroundRogers, J. M., Heintz, M. M., Thompson, C. M., & Haws, L. C. (2023) · Birth Defects Research · doi:10.1002/bdr2.2185 · Cited by 21
“Dietary exposure to ammonium PFOA (300 ppm) in male rats also decreased serum glucose levels after 8 days of treatment (Elcombe et al., 2010).”
BackgroundInfluentialBeltrán-Ramírez, O., Macías-Pérez, J. R., Sierra‐Santoyo, A., & Villa‐Treviño, S. (2012) · Toxicologic Pathology · doi:10.1177/0192623311431947 · Cited by 16
“Prolonged treatment with phenobarbital and phyrethrins results in the formation of altered hepatic foci and liver tumors (Elcombe et al. 2010; Kamino et al. 2011; Tien and Negishi 2006).”
BackgroundCurrent developments in toxicology
Stewart, J. D., & Marchan, R. (2012) · Europe PMC (PubMed Central) · doi:10.4126/frl01-006402685 · Cited by 14
Sukhotnik, I., Nissimov, N., Ben‐Shahar, Y., Moati, D., Bitterman, N., Pollak, Y., Berkowitz, D., Coran, A. G., & Bitterman, A. (2016) · Pediatric Surgery International · doi:10.1007/s00383-016-3979-x · Cited by 15
“A previous study demonstrated that PPARa agonist administration significantly increased cell proliferation of cells colabeled by BrdU and PPARa in the striatum and the cortex after focal cerebral ischemia [25] and stimulated hepatocellular proliferative response following liver damage by toxins [26].”
BackgroundButenhoff, J. L., Olsen, G. W., & Chang, S. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.02.017 · Cited by 18
Self-citationNanotoxicology and oxidative stress control: cutting-edge topics in toxicology
Bolt, H. M., Marchan, R., & Hengstler, J. G. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0953-9 · Cited by 10
“…perfluorooctanoate, used in the production of fluoropolymers, induces hepatocellular hypertrophy in rats by activation of the nuclear receptors, PPAR alpha and CAR/PXR (10) Elcombe et al. (2010) Formaldehyde causes nasal cancer and lymphohematopoietic malignancies (LHM) in laboratory animals.”
BackgroundKasten‐Jolly, J., & Lawrence, D. A. (2022) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2022.2075816 · Cited by 11
“Initially, it was postulated that the activation of the peroxisome proliferativeactivated receptor-alpha (PPARα) by PFOA was initiating this decrease in IgM (Corton et al. 2014; Elcombe et al. 2010; Klaunig et al. 2003; Klaunig, Hocevar, and Kamendulis 2012; Yang et al. 2002, 2001).”
BackgroundShin, M.-W., Kang, H., & Kim, S.-H. (2025) · Toxics · doi:10.3390/toxics13020091 · Cited by 12
Huacachino, A. A., Chung, A., Sharp, K. A., & Penning, T. M. (2024) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2024.106641 · Cited by 8
Chi, Y., Park, J., Na, S., & Kwak, K. (2023) · Annals of Occupational and Environmental Medicine · doi:10.35371/aoem.2023.35.e27 · Cited by 9
The reversal of PXR or PPARα activation-induced hepatomegaly
Zhang, Y., Yang, J., Fan, S., Gao, Y., Cai, C., Li, H., Li, X., Xiao, Y., Xing, Y., Huang, M., et al. (2024) · Toxicology Letters · doi:10.1016/j.toxlet.2024.05.006 · Cited by 6
Tu, L., Yang, Y., Lin, Y., Wang, X., Peng, H., Chen, B., Zhang, R., & Luan, T. (2024) · Environmental Science & Technology · doi:10.1021/acs.est.4c06425 · Cited by 10
Indispensable role of PGC1α signaling in lipid and carbohydrate metabolism of fish PPARα activation
Zhang, H., Chen, X., Hua, R., Chen, B., Guang, J., Pan, Q., Wen, X., & Ning, L. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141722 · Cited by 4
Rahman, H. H., Stokey, W. R., & Munson‐McGee, S. H. (2025) · Food and Chemical Toxicology · doi:10.1016/j.fct.2025.115853 · Cited by 5
Bioaccumulation of PFOS Isomers in Transporter Proteins
James, D., Paddayuman, J. Z., Cristobal, J. R., Loganathan, N., Atilla‐Gokcumen, G. E., Aga, D. S., & Wilson, A. K. (2026) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5c00432 · Cited by 7
Corton, J. C., Gift, J. S., Auerbach, S. S., Liu, J., Das, K. P., Ren, H., Lang, J. R., Chernoff, N., Lau, C. S., & Hill, D. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf042 · Cited by 4
Effects of camel milk on drug metabolising cytochrome P450 enzymes expressions in rats
Ibrahim, Z. S., Ahmed, M. M., El-Shazly, S. A., & Alkafafy, M. (2016) · Journal of Camel Practice and Research · doi:10.5958/2277-8934.2016.00004.7 · Cited by 4
Mixture effects of co-formulants and two plant protection products in a liver cell line
Feiertag, K., Karaca, M., Fischer, B. C., Heise, T., Bloch, D., Opialla, T., Tralau, T., Kneuer, C., & Marx‐Stoelting, P. (2023) · EXCLI journal · doi:10.17179/excli2022-5648 · Cited by 8
PFOA biomonitoring and kidney cancer risk: a meta-analysis of serum levels
Spyrakis, F., Tiburtini, G. A., Bruno, S., Dragani, T. A., & Colombo, F. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1593300 · Cited by 6
Molecular Pathways of Emerging Pollutants in the Marine Ecosystem
Liu, Y., & Pei, D. (2025) · Springer eBooks · doi:10.1007/978-3-031-75713-6_10 · Cited by 7
Zhang, X., Sun, K., Wang, X., Xu, S., & Gong, D. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-22285-5 · Cited by 3
Li, X., Wang, Z., Wu, Q., & Klaunig, J. E. (2024) · Journal of Environmental Science and Health Part C · doi:10.1080/26896583.2024.2327969 · Cited by 4
Heuvel, J. P. V. (2013) · Environment International · doi:10.1016/j.envint.2013.09.004 · Cited by 5
Phytomediated Approach for Management of Emerging Pollutants
Odoh, U. E., & Micheal, C. O. (2023) · Springer eBooks · doi:10.1007/978-3-031-41005-5_7 · Cited by 1
Introduction of emerging pollutants and marine bivalve mollusks
Zhou, W., Huang, L., Shi, W. M., & Liu, G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19117-6.00005-2 · Cited by 2
Chang, S., Parker, G. A., Kleinschmidt, S. E., Olsen, G. W., Ley, C. A., & Taiwo, O. A. (2020) · Toxicologic Pathology · doi:10.1177/0192623320911606 · Cited by 1
Self-citationBorg, D. (2013) · Figshare · Cited by 2
Guyton, K. Z., & Waters, M. D. (2016) · Royal Society of Chemistry eBooks · doi:10.1039/9781782624059-00247
(2011) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32834ee42b
Potential effect of co-exposure to Per- and polyfluoroalkyl substances on the risk of insomnia
Zhang, Z., Li, N., Yang, Z., Jin, M., Liu, X., Zhang, Y., Lin, N., Li, Z., Zhuang, L., Bao, H., et al. (2025) · Hygiene and Environmental Health Advances · doi:10.1016/j.heha.2025.100163 · Cited by 1
Perfluorooctane Sulfonate (PFOS) Disrupts Mitochondrial Activity and Cell Adhesion in Liver Cells
Tran, P. D., & Kim, K. (2026) · Journal of Xenobiotics · doi:10.3390/jox16020065 · Cited by 1
Water pollutants: An increasingly etiological factor for liver cancer
Su, C.-X., Sun, Q., Han, X., & Qiu, Y.-D. (2026) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2026.07.006 · Cited by 1
Goksøyr, S. Ø., Karlsen, O. A., Ruivo, R., Castro, L. F. C., & Goksøyr, A. (2026) · ACS ES&T Toxicology · doi:10.1021/acsesttox.6c00014
Metadata
- Authors
- Elcombe, C. R., Elcombe, B. M., Foster, J. R., Farrar, D. G., Jung, R., Chang, S.-C., Kennedy, G. L., & Butenhoff, J. L.
- Affiliations
- AstraZeneca (United Kingdom) (GB)
- Ineos (United Kingdom) (GB)
- Clariant (Germany) (DE)
- 3M (United States) (US)
- DuPont (United States) (US)
- Corresponding author
- Butenhoff, John L.
- Venue
- Archives of Toxicology
- Published
- 2010-07-08
- Volume
- 84
- Issue
- 10
- Pages
- 787-798
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- OpenAlex
- W2005561403
- Cited by
- 96
- References
- 42
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 6 · 2023: 6 · 2022: 5 · 2021: 4 · 2020: 6 · 2019: 2 · 2018: 5 · 2017: 5 · 2016: 8 · 2015: 5 · 2014: 6 · 2013: 3 · 2012: 12
- FWCI
- 7.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Archives of Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- Topics
- Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
- Keywords
- ammonium perfluorooctanoate, PPARα, hepatocyte hypertrophy, hepatocyte proliferation, hepatomegaly, Wy-14,643, peroxisomal beta-oxidation, CYP4A1, CYP2B1/2, CYP3A1, apoptosis, non-genotoxic carcinogens
- MeSH terms
- Pregnane X Receptor, Constitutive Androstane Receptor, Animals, Body Weight, Caprylates, Cytochrome P-450 Enzyme System, DNA, Environmental Pollutants, Fluorocarbons, Hepatomegaly, Hypertrophy, Liver, Male, Organ Size, Receptors, Steroid, Rats, Sprague-Dawley, Apoptosis, Receptors, Cytoplasmic and Nuclear, Peroxisomes, Hepatocytes, PPAR alpha, Cell Proliferation, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.